- Country: Costa Rica
- Summary: Insulin Lispro 100 U/Ml. Injectable Solution. Non-Refillable Prefilled Pen-Type Dispensing Device with 3 Ml. for Multiple Doses Code. 1-10-39-4152 (Art. 55 Lgcp)
- CRT Ref No: 134672820
- Deadline: 18 Feb 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: CRC 314455014.00
- Notice Type: Tender
- Document Ref. No.:Login to see details
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINInsulin Lispro 100 U/Ml. Injectable Solution. Non-Refillable Prefilled Pen-Type Dispensing Device with 3 Ml. for Multiple Doses Code. 1-10-39-4152 (Art. 55 Lgcp) - Costarica Tender
The COSTA RICAN SOCIAL SECURITY FUND, a Government sector organization in Costa Rica, has announced a new tender for Insulin Lispro 100 U/Ml. Injectable Solution. Non-Refillable Prefilled Pen-Type Dispensing Device with 3 Ml. for Multiple Doses Code. 1-10-39-4152 (Art. 55 Lgcp). This tender is published on CostaricaTenders under CRT Ref No: 134672820 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-02-18.
The estimated tender value is CRC 314455014.00, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
